Focusing on the six genes that strengthened the malignant phenotype in HCC (TPX2, KIF4A, UBE2S, RAN, BCAR3, YWHAG), we found that they are all associated with the PI3K/AKT pathway. This evidence concerns the gene RAN and hepatocellular carcinoma.